BIOCRYST PHARMACEUTICALS
(09058v103)
Fondsberichterstattung Bestände von BIOCRYST PHARMACEUTICALS gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Baker BROS Advisors LP | 14,382,673 | $54,510k | Jun 30, 2019 | Aug 14, 2019 | |
| Deerfield Management Company LP Series C | 6,292,980 | $23,850k | Jun 30, 2019 | Aug 14, 2019 | |
| Ghost Tree Capital LLC | 2,500,000 | $9,475k | Jun 30, 2019 | Aug 14, 2019 | |
| Dafna Capital Management LLC | 410,888 | $1,557k | Jun 30, 2019 | Aug 14, 2019 | |
| Premier Asset Management LLC | 192,765 | $730k | Jun 30, 2019 | Aug 7, 2019 | |
| Sofinnova Ventures Inc | 181,159 | $687k | Jun 30, 2019 | Aug 13, 2019 | |
| Spark Investment Management LLC | 82,400 | $312k | Jun 30, 2019 | Aug 12, 2019 | |
| SIO Capital Management LLC | 38,700 | $147k | Put | Jun 30, 2019 | Aug 14, 2019 |
| Prelude Capital Management LLC | 3,587 | $14k | Jun 30, 2019 | Aug 14, 2019 |